California's Medicaid Reimbursements for Clinical Diagnostic Laboratory Services
Learn how the AI-generated research projects were createdOverall Conclusion
The State agency did not always claim Federal Medicaid reimbursement for clinical diagnostic laboratory services in accordance with Federal and State requirements, resulting in overpayments totaling $13.9 million (Federal share) and potentially $29.3 million (Federal share not specified in the summary). The overpayments arose from failure to update rate tables; the State concurred with the recommendations and described corrective actions.
Source Document
Audit Scope
Calendar years 2019–2023, California's fee-for-service Medicaid payments for clinical diagnostic laboratory services, limited to claim types 8013 (hospital outpatient), 8014 (hospital lab services to nonpatients), and 8700 (professional), with HCPCS codes on the Medicare fee schedules; totaled 36,252,751 services and $632,164,882 paid ($345,122,316 Federal share) during the audit period; 3,123,613 services reviewed for overpayments totaling $107,508,910 ($59,616,155 Federal share).
Key Findings Summary
For 2,186,277 of 3,123,613 services reviewed, California paid providers more than they would have been paid under the Medicare CLFS or the amounts allowed by State requirements.
Additionally, for 211,171 services, California potentially paid providers more than they would have been paid under the Medicare program or the amounts allowed by State requirements for GDSP services; CMS-SPA status unclear prior to SPA approvals.
The overpayments occurred because the State agency did not follow its policies and procedures for reviewing and updating laboratory rates in its claims processing system, attributed to a clerical error.
View the Findings tab to see all 4 findings
AI-Assisted
AI Scope Summary
This audit builds on prior OIG work by focusing on the integrity of rate-setting and reimbursement practices in California's Medicaid program for laboratory services, with emphasis on GDSP-related claims and SPAs, and provides a framework for future audits to assess rate-table governance, cross-program oversight, and post-audit remediation.
AI-Generated Insight
The audit underscores the importance of robust rate-table maintenance and automated controls in Medicaid claims processing to prevent overpayments, especially when SPAs and GDSP providers complicate reimbursement calculations.
Audit Objectives
Determine whether the State agency claimed Federal Medicaid reimbursement for clinical diagnostic laboratory services in accordance with the payment limits set in Federal and State requirements (calendar years 2019–2023).
Audit Findings (4)
For 2,186,277 of 3,123,613 services reviewed, California paid providers more than they would have been paid under the Medicare CLFS or the amounts allowed by State requirements.
Additionally, for 211,171 services, California potentially paid providers more than they would have been paid under the Medicare program or the amounts allowed by State requirements for GDSP services; CMS-SPA status unclear prior to SPA approvals.
The overpayments occurred because the State agency did not follow its policies and procedures for reviewing and updating laboratory rates in its claims processing system, attributed to a clerical error.
In total, the Federal reimbursement claimed exceeded the rates allowed by Federal and State requirements by $13,892,037 ($7,576,103 Federal share) and potentially exceeded by $29,319,373 ($16,477,416 Federal share).
Recommendations (4)
Refund $7,576,103 to the Federal Government.
Work with CMS to determine whether potential overpayments of $16,477,416 (Federal share) complied with Federal and State requirements and refund the Federal share of any overpayments to the Federal Government.
Review payments made after the audit period to identify any additional overpayments and refund the Federal share to the Federal Government; clearly identify refunds as such.
Evaluate and strengthen existing policies and procedures for reviewing and updating rates in the claims processing system to ensure that amounts claimed do not exceed Medicare or State requirements.